Publications

Search by keyword

Type

Member

featured publications

Health-related quality of life and caregiver burden of emicizumab in children with haemophilia A and factor VIII inhibitors-Results from the HAVEN 2 study.

21/10/2020 Haemophilia : the official journal of the World Federation of Hemophilia

Authors: Maria Elisa Mancuso, Johnny Mahlangu, Robert Sidonio, Peter Trask, Marianne Uguen, Tiffany Chang, Midori Shima, Guy Young, Johannes Oldenburg, Sylvia von Mackensen
View this publication
Quality of electronic treatment records and adherence to prophylaxis in haemophilia and von Willebrand disease: Systematic assessments from an electronic diary.

21/10/2020 Haemophilia : the official journal of the World Federation of Hemophilia

Authors: Andreas Tiede, Santiago Bonanad, Amparo Santamaria, Georg Goldmann, Mariana Canaro, Antonio Palomero, Luis J G Frade, Juan Eduardo Megias-Vericat, Fernanda Martinez, Faustino Garcia Candel, Victor Jimenez Yuste, Monika Sparber-Sauer, Susan Halimeh, Daniela Adolf, Martin Hukauf, Jan Reichmann, Johannes Oldenburg
View this publication
Molecular Analysis of Fetal and Adult Primary Human Liver Sinusoidal Endothelial Cells: A Comparison to Other Endothelial Cells.

21/10/2020 International journal of molecular sciences

Authors: Muhammad Ahmer Jamil, Heike Singer, Rawya Al-Rifai, Nicole Nüsgen, Melanie Rath, Sascha Strauss, Ioanna Andreou, Johannes Oldenburg, Osman El-Maarri
View this publication
Optimizing the management of patients with haemophilia A and inhibitors in the era of emicizumab: Recommendations from a German expert panel.

16/09/2020 Haemophilia : the official journal of the World Federation of Hemophilia

Authors: Carmen Escuriola-Ettingshausen, Günter Auerswald, Christoph Königs, Karin Kurnik, Ute Scholz, Robert Klamroth, Johannes Oldenburg
View this publication
Infiltration and Clustering of Major Histocompatibility Complex II Antigen-Presenting Cells in the Skin of Patients with Atopic Dermatitis.

06/09/2020 The Journal of investigative dermatology

Authors: Wenming Peng, Bartlomiej Kwiek, Chunfeng Yu, Natalio Garbi, Jean-Pierre Allam, Johannes Oldenburg, Natalija Novak
View this publication
Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS-IPS, an international and collaborative cross-sectional study.

25/08/2020 Journal of thrombosis and haemostasis : JTH

Authors: Alberto Tosetto, Zahra Badiee, Mohammad-Reza Baghaipour, Luciano Baronciani, Javier Battle, Erik Berntorp, Imre Bodó, Ulrich Budde, Giancarlo Castaman, Jeroen C J Eikenboom, Peyman Eshghi, Cosimo Ettorre, Anne Goodeve, Jenny Goudemand, Charles Richard Morris Hay, Hamid Hoorfar, Mehran Karimi, Bijan Keikhaei, Riitta Lassila, Frank W G Leebeek, Maria Fernanda Lopez Fernandez, Pier Mannuccio Mannucci, Maria Gabriella Mazzucconi, Massimo Morfini, Johannes Oldenburg, Ian Peake, Rafael Parra Lòpez, Flora Peyvandi, Reinhard Schneppenheim, Andreas Tiede, Gholamreza Toogeh, Marc Trossaert, Omidreza Zekavat, Eva M K Zetterberg, Augusto B Federici
View this publication
Molecular Insights and Functional Consequences of the Interaction of Heme with Activated Protein C.

20/08/2020 Antioxidants & redox signaling

Authors: Marie-Thérèse Hopp, Nour Alhanafi, Ajay Abisheck Paul George, Nasim Shahidi Hamedani, Arijit Biswas, Johannes Oldenburg, Bernd Pötzsch, Diana Imhof
View this publication
Outcomes in children with hemophilia A with inhibitors: Results from a noninterventional study.

09/08/2020 Pediatric blood & cancer

Authors: Johannes Oldenburg, Midori Shima, Rebecca Kruse-Jarres, Elena Santagostino, Johnny Mahlangu, Michaela Lehle, Nives Selak Bienz, Sammy Chebon, Elina Asikanius, Peter Trask, Maria Elisa Mancuso, Victor Jiménez-Yuste, Sylvia von Mackensen, Gallia G Levy
View this publication
Further Evidence That MicroRNAs Can Play a Role in Hemophilia A Disease Manifestation: Gene Downregulation by miR-19b-3p and miR-186-5p.

30/07/2020 Frontiers in cell and developmental biology

Authors: Katarzyna I Jankowska, Joseph McGill, Behnaz Pezeshkpoor, Johannes Oldenburg, Zuben E Sauna, Chintamani D Atreya
View this publication
Origins, Development, Current Challenges and Future Directions with Activated Prothrombin Complex Concentrate for the Treatment of Patients with Congenital Haemophilia with Inhibitors.

27/07/2020 Hamostaseologie

Authors: Hans H Brackmann, Wolfgang Schramm, Johannes Oldenburg, Viridiana Cano, Peter L Turecek, Claude Négrier
View this publication

Health-related quality of life and caregiver burden of emicizumab in children with haemophilia A and factor VIII inhibitors-Results from the HAVEN 2 study.

Quality of electronic treatment records and adherence to prophylaxis in haemophilia and von Willebrand disease: Systematic assessments from an electronic diary.

Molecular Analysis of Fetal and Adult Primary Human Liver Sinusoidal Endothelial Cells: A Comparison to Other Endothelial Cells.

Optimizing the management of patients with haemophilia A and inhibitors in the era of emicizumab: Recommendations from a German expert panel.

Infiltration and Clustering of Major Histocompatibility Complex II Antigen-Presenting Cells in the Skin of Patients with Atopic Dermatitis.

Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS-IPS, an international and collaborative cross-sectional study.

Molecular Insights and Functional Consequences of the Interaction of Heme with Activated Protein C.

Outcomes in children with hemophilia A with inhibitors: Results from a noninterventional study.

Further Evidence That MicroRNAs Can Play a Role in Hemophilia A Disease Manifestation: Gene Downregulation by miR-19b-3p and miR-186-5p.

Origins, Development, Current Challenges and Future Directions with Activated Prothrombin Complex Concentrate for the Treatment of Patients with Congenital Haemophilia with Inhibitors.